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CASE HISTORY
A 27-year-old male presented with mild unsteadiness of gait of two years' duration. Since childhood he had had enuresis and occasional faecal incontinence. From the age of eight he had had recurrent episodes of upper abdominal pain and anorexia which had been severe enough on several occasions to necessitate admission to hospital, although a precise diagnosis of the cause was never made. Between episodes, his appetite was not good and he never attained a weight greater than 120 lbs. During his teenage years he acquired a great fondness for potato crisps and salted peanuts and he often added copious amounts of salt to his food. In his early 20s he had a particularly severe episode of anorexia, vomiting and abdominal pain while on a summer holiday in Spain. Despite feeling exceedingly weak, he made his way back to London by plane, and, without seeking medical attention, checked into a hotel where he spent his time in his room drinking a lot of fluid and eating many packets of potato crisps and peanuts, so that three days later he was able to emerge feeling more or less back to normal. Puberty occurred normally in his mid -teens but he became aware of difficulty in penile erection; this symptom persisted together with the disturbance of bladder control which had been present since childhood. He became unsteady on his feet at about the age of 25. His neurological symptoms have not changed significantly during the three years he has been under observation. He has had no sensory symptoms in his limbs nor any visual symptoms and, in particular, colour vision is intact. He was an adopted child and has no knowledge of his family background. Examination revealed a thin well -tanned young man with pigmentation of the lips and buccal mucosa. Development of secondary sexual characteristics was normal. Blood pressure was 120/70 mmHg lying and standing. His speech function was normal, colour vision unimpaired and function of the cranial nerves intact. In the limbs there was a mild spasticity of arms and legs together with mild The Ulster Medical Journal weakness of hip flexors and ataxia on heel -shin testing bilaterally. The tendon reflexes were generally brisk with bilateral extensor plantar responses. On sensory testing vibration sense was absent to the knees, and position sense defective at both great toes. Pin prick and light touch were unimpaired. He had a spastic ataxic gait. Serum urea and electrolytes, blood count, sedimentation rate, serum B12 and folic acid levels were all normal. Cerebrospinal fluid analysis and myelogram were normal. Sensory evoked responses were delayed at spinal and cortical levels. Motor and sensory conduction in the peripheral nerves were normal. Visual evoked responses and auditory evoked responses were also normal. CT scan of the brain was normal. The diagnosis of primary adrenal insufficiency was confirmed by serum cortisol levels of 150 nmol/l and 140 nmol/l at 0700 and 2300 h respectively and 140 nmol/l 30 minutes after an intravenous injection of 0.25 mg tetracosactrin (Synacthen), and a random plasma ACTH of 1150 ng/l (normal < 70). Adrenal autoantibodies were not detected. Plasma levels of very long chain (C24 -30) fatty acids, measured by gas liquid chromatography,' are shown in the Table. After replacement therapy with hydrocortisone and fludrocortisone his appetite and weight have increased, as has his general strength, but some three years after diagnosis his neurological symptoms and signs are unchanged. 
DISCUSSION
The findings of primary adrenocortical failure together with a mild spastic ataxic paraparesis and an elevated plasma level of very long chain fatty acids established the diagnosis of adrenomyeloneuropathy,2 and to our knowledge this is the first case described in Ulster. Adrenomyeloneuropathy is a rare X 4linked recessive disorder. A variant, adrenoleukodystrophy, was first described in 19233 and both forms may occur in one family. The first features of adrenomyeloneuropathy are symptoms of adrenal insufficiency beginning in the first or second decade followed by the appearance of a progressive myelopathy during the third or fourth decade,4 and often accompanied by a cerebellar ataxia and sphincter disturbance as in the present case. Features of a peripheral neuropathy may also occur. The precise aetiology of the condition is unknown but the accumulation of saturated unbranched very long chain fatty acids in tissues and body fluids is characteristic,2 suggesting an inherited defect in some enzyme(s) involved in fatty acid metabolism. Cytoplasmic inclusion bodies, which may be detected in the brain, spinal cord, adrenal and testicular tissue are thought to represent breakdown products of very long chain fatty acids. 5 Although the hypoadrenalism can be satisfactorily treated with corticosteroids as in Addison's disease, correction of the hypoadrenal state does not modify the progressive neurological course.2 Perhaps the most remarkable aspect of this case has been the patient's ability to fend off any serious metabolic catastrophe for a 20-year period through copious salt ingestion. Salt hunger has long been recognised as a feature of Addison's disease6 but such prodigious efforts must be exceptional! Detection of 'carriers' to facilitate genetic counselling should represent an important part of the overall management of any inheritable progressive disorder lacking specific curative therapy. One report suggested that females, heterozygous for the condition, may be identified by abnormal auditory evoked responses,7 but the finding of normal responses in our patient who has well developed features of the syndrome must cast doubt on this. A more promising approach to the detection of heterozygotes lies in the measurement of plasma very long chain fatty acids, which have been-shown to be elevated in carriers as well as in patients. 1, 2 We are indebted to Dr H W Moser, Director of the John F Kennedy Institute, Baltimore, Maryland, for measuring plasma fatty acid levels in this patient. We would like to thank Miss Angela Gibney for typing the manuscript.
